Assessment and management of ADR associated with cancer chemotherapy in a tertiary care hospital

Registration ID: IJNRD_193875

Published ID: IJNRD2305055

DOI: http://doi.one/10.1729/Journal.34089

Kadeejath Thashrifa Shereen B , Risvana Abdul Rahiman P , Karthik MM , Shama Banu KP , Dr. Suja C

Adverse drug reaction, causality, chemotherapy, pharmacovigilance.

Aim: The objective of the study was to assess the causality, severity and preventability of ADRs detected by chemotherapeutic medications and to assess their management. Methodology: A prospective observational study was conducted for 6 months among 108 patients. Results: The study found a total of 263 ADRs, with the gastrointestinal system being the most affected organ system (28.6%).The drug Paclitaxel caused the highest number of ADRs when administered as monotherapy, while paclitaxel+carboplatin caused the highest number of ADRs when taken in combination. Causality was assessed using Naranjo’s causality assessment scale, it was found that 87.1% of the ADRs were probable, 7.6% were possible, and 5.3% were definite. The severity of ADRs was assessed using the Hartwig & Siegal scale, and the study found that 49.8% of ADRs were moderate level 3, 34.6% were moderate level 4a, 10.3% were mild level 2, 4.2% were moderate level 4b, and 1.1% were mild level 1.The preventability of the ADRs was assessed using the Modified Schumock and Thornton preventability scale, it was found that 68.4% of ADRs were not preventable, 18.6% were probably preventable, and 12.9% were definitely preventable. The study also found that the ADRs were managed by providing additional treatment without changing the drug regimen. Conclusion : ADRs are the major concern in patient safety and are responsible for a significant amount of mortality and morbidity, as well as financial burden on patients. It is essential to keep ADR in track, and early detection/ monitoring could help reduce the risk of one’s health.

Published Paper   E-Certificate

Kadeejath Thashrifa Shereen B , Risvana Abdul Rahiman P, Karthik MM, Shama Banu KP, & Dr. Suja C (May-2023). Assessment and management of ADR associated with cancer chemotherapy in a tertiary care hospital . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(5), a422-a447. http://doi.one/10.1729/Journal.34089

Volume 8 Issue 5, May-2023

Pages : a422-a447

Paper Reg. ID: IJNRD_193875

Published Paper Id: IJNRD2305055

Downloads: 000121989

Research Area: Pharmacy

Country: Kasaragod, Kerala, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2305055.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2305055

Crossref DOI: http://doi.one/10.1729/Journal.34089

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 9 | September 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: September 2025

Current Issue: Volume 10 | Issue 9 | September 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details